N/A
Completed N=70
Sharing Decision-making Program for HCC Patients Treatment Decisions
Source: ClinicalTrials.gov NCT03926039 ↗Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Decisional Conflict Scale — 6.9; 11 score on a scale — p=0.05
Summary
Aim: Explore the effectiveness of sharing decision-making program interventions in the early stage of HCC to reduce treatment decisions conflicts and improving decision-making satisfaction.
Design: An experimental design will be used in the study. The 102 primary liver cancer patients, who were diagnosed with Barcelona stage(BCLC stage) 0-A, will be recruited and randomized to the control or intervention group. The intervention measures in this study "sharing decision-making plan" mainly includes sharing the decision-making talks and the decision-making assistance tools used in the process.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Decisional Conflict Scale |
6.9; 11 | 0.05 |
| SECONDARY Satisfaction With Decision Instrument |
26.2; 27.1 | — |
| SECONDARY Decision Self-efficacy Scale |
73.3; 72.1 | — |
| SECONDARY Liver Cancer Treatment Options Related Knowledge Scale |
84.6; 75.6 | — |
Eligibility Criteria
Inclusion Criteria
- Primary liver cancer patients (ICD 10 is C22.0) and Barcelona stage (BCLC stage) 0-A.
- At least 20 years of age.
- No mental illness.
- Patients who can communicate in Mandarin or Taiwanese.
Exclusion Criteria
- Don't know himself condition.
- Unconscious patients.
- Patients with liver cancer resection or partial liver resection were performed within 3 months.
Data sourced from ClinicalTrials.gov (NCT03926039). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.